Titrating ADHD Medication to an Optimal Dose

In "Titrating ADHD Medication to an Optimal Dose," the panelists get specific about how assertively to titrate an adult patient's ADHD medication once treatment begins.

The panel discusses how aggressively to titrate ADHD medication once treatment begins. For appropriate patients, providers can often titrate several times between visits, reaching a dose close to optimal well before the standard four-week follow-up rather than waiting passively. Some patients, the panel notes, land on an optimal dose from the very first prescription, though most require ongoing adjustment. The panel stresses balancing an appropriately assertive titration pace with careful attention to tolerability, and notes this balance shifts depending on the individual patient: some tolerate side effects better while waiting for full efficacy, while others need efficacy to arrive quickly even at the cost of more initial side effects. Knowing each patient well enough to judge which approach fits them is essential to successful titration.

The panel also addresses patients who arrive "snakebit" from a previous bad medication experience, describing the importance of acknowledging that history directly and explaining clearly how the new approach and expectations will differ. Trust between patient, provider, and family members proves crucial to this process. Panelists observe that many patients who report a poor experience with a prior medication actually describe feeling unheard by their previous provider even more than they describe the drug itself, and that this compounds any negative pharmacologic experience. The panel notes that well-meaning providers who stay within a narrow set of familiar medications may unintentionally underserve patients who need a different option. Expanding clinical comfort with the full range of available ADHD treatments, the panel argues, allows providers to serve significantly more patients well, which the panelists identify as a central reason for sharing this discussion.

The series closes with "Tailoring Extended-Release ADHD Treatment Around the Clock," as the panel tailors extended-release strategies to cover patients from first thing in the morning through bedtime.